Lates News
GlaxoSmithKline said that the company's investment will include $1.2 billion for advanced manufacturing, artificial intelligence (AI), and advanced digital technology. The investment commitment was made during US President Trump's three-day state visit to the UK. In response to pressure from the Trump administration to boost American manufacturing and lower domestic drug prices, large pharmaceutical companies are flocking to invest in the US.
Latest